Cannabinoids Market Report 2026

Cannabinoids Market Overview

• Cannabinoids market size has reached to $47.03 billion in 2025 • Expected to grow to $120.57 billion in 2030 at a compound annual growth rate (CAGR) of 20.7% • Growth Driver: Cannabinoids Market Surges Amidst Rising Prevalence Of Chronic Diseases • Market Trend: Innovative Advancements In Fast-Acting Cannabinoids • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cannabinoids Market?

Cannabinoids refer to a particular marijuana chemical that has effects similar to those of drugs across the immunological and central nervous systems. The cannabinoid is used to treat the side effects or symptoms of chronic diseases, like cancer treatment. The main product type of cannabinoids includes cannabidiol, tetrahydrocannabinol, cannabinol and other product types. Cannabidiol is used to treat patients suffering from seizures, anxiety, insomnia, chronic pain, and tobacco addiction. Cannabidiol refers to a chemical that is found in the cannabis sativa plant or hemp. The distribution type of cannabinoids includes hospital pharmacies, retail pharmacies and online stores. The application includes medical, recreational and industrial hemp.

What Is The Cannabinoids Market Growth Forecast?

The cannabinoids market size is expected to see exponential growth in the next few years. It will grow to $120.57 billion in 2030 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to expansion of clinical research on cannabinoids, increasing demand for pharmaceutical-grade cannabinoid products, rising regulatory clarity across regions, growth of cannabinoid-based personalized medicine, increasing investments in cannabinoid manufacturing infrastructure. Major trends in the forecast period include increasing medical adoption of cannabinoid-based therapies, rising demand for cbd-dominant products, growing use of cannabinoids in chronic disease management, expansion of regulated cannabinoid supply chains, enhanced focus on product standardization and purity.

Global Cannabinoids Market Segmentation

1) By Product Type: Cannabidiol, Tetrahydrocannabinol, Cannabinol, Other Product Types 2) By Distribution: Hospital Pharmacies, Retail Pharmacies, Online Stores 3) By Application: Medical, Recreational, Industrial Hemp Subsegments: 1) By Cannabidiol (CBD): Full-Spectrum CBD, Broad-Spectrum CBD, CBD Isolate 2) By Tetrahydrocannabinol (THC): Delta-9 THC, Delta-8 THC 3) By Cannabinol (CBN): CBN Isolate, CBN Oil 4) By Other Product Types: Cannabigerol (CBG), Cannabichromene (CBC)

What Is The Driver Of The Cannabinoids Market?

The rising prevalence of chronic diseases is expected to propel the cannabinoid market. Chronic diseases refer to illnesses that last a year or longer and require ongoing medical attention. The effectiveness of cannabinoids, such as smoked marijuana, oromucosal extracts of cannabis-based medication, nabilone, dronabinol, and a new THC analogue, in the treatment of chronic noncancer pain, was examined in a systematic review of randomized controlled trials. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency. in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. As a result, the rising prevalence of chronic diseases is driving the growth of the cannabinoid industry.

Key Players In The Global Cannabinoids Market

Major companies operating in the cannabinoids market are The Supreme Cannabis Company Inc., Elixinol Global Limited, GW Pharmaceuticals PLC, Tilray Inc., Aurora Cannabis Inc., Curaleaf Holdings Inc., Green Thumb Industries, Verano Holdings, Trulieve Cannabis Corp., Cresco Labs Inc., Cronos Group, TerrAscend Corp., Canopy Growth Corp., Sundial Growers Inc., Decibel Cannabis Company, Auxly Cannabis Group, Red White & Bloom Brands, BZAM Ltd, Delta 9 Cannabis Inc., Jazz Pharmaceuticals PLC, Aphria Inc., Organigram Inc., MediPharm Labs Corp., The Valens GroWorks Inc.

Global Cannabinoids Market Trends and Insights

Major companies operating in the cannabinoids market are focusing on developing innovative solutions, such as fast-acting cannabinoids, to enhance the efficacy and speed of therapeutic effects. Fast-acting cannabinoids refer to cannabinoid formulations that produce quicker therapeutic effects after consumption compared to traditional delivery methods. For instance, in August 2024, Rare Cannabinoid, a US-based health and wellness company, launched Fast-Acting Nano THC + CBC Mood Mints, expanding its popular mood product line with an innovative delivery method. These mints are designed to provide rapid effects, allowing users to experience the benefits of delta-9-THC and cannabichromene (CBC) within 15 to 30 minutes, compared to the typical 30 to 90 minutes for traditional edibles. Utilizing advanced nanotechnology, the mints offer flexible dosing options suitable for both microdosing and individualized needs.

What Are Latest Mergers And Acquisitions In The Cannabinoids Market?

In April 2023, MediPharm Labs Corp., a Canada-based producer of medical and recreational cannabis products, acquired VIVO Cannabis Inc., for an undisclosed amount. With this acquisition, MediPharm Labs aims to expand its production capacity, strengthen its market presence in the Canadian cannabis sector, enhance product diversification, and improve operational efficiencies across its cultivation and extraction facilities. VIVO Cannabis Inc. is a Canada-based, licensed cannabis producer specializes in producing high-quality cannabis products for both medical and adult-use markets.

Regional Outlook

North America was the largest region in the cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cannabinoids Market?

The cannabinoids market consists of sales of cannabidiolic acid, flowers/buds and concentrates. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cannabinoids Market Report 2026?

The cannabinoids market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cannabinoids industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.